Business Context and Reporting Period
Runway Growth Finance Corp. (RWAY) is an externally managed, non-diversified closed-end management investment company regulated as a Business Development Company (BDC) and taxed as a Regulated Investment Company (RIC). The company focuses on providing senior secured loans and hybrid debt/equity financing to high-growth private companies in technology, healthcare, business services, and financial services. This filing covers the fiscal year ended December 31, 2025.
Key Financial Metrics (Year Ended December 31, 2025)
| Metric | Value |
|---|---|
| Investment Portfolio (Fair Value) | $927.4 million |
| Net Asset Value (NAV) | $485.0 million |
| NAV Per Share | $13.42 |
| Total Investment Income | $137.3 million |
| Net Investment Income | $56.9 million ($1.55 per share) |
| Net Increase in Net Assets from Operations | $34.0 million ($0.93 per share) |
| Total Operating Expenses | $80.4 million |
| Debt Outstanding | $437.3 million |
| Asset Coverage Ratio | 211% |
| Portfolio Yield (Dollar-Weighted) | 14.6% |
| Distributions Declared | $51.4 million ($1.40 per share) |
Material Changes vs. Prior Period
- Portfolio Contraction: The investment portfolio fair value decreased by approximately 13.9% from $1.077 billion in 2024 to $927.4 million in 2025, driven by sales and prepayments of $287.0 million and net unrealized losses of $25.7 million.
- Income Decline: Total investment income decreased 5.1% to $137.3 million, primarily due to falling interest rates and a reduction in the average outstanding principal of interest-earning debt investments.
- Net Income Reduction: Net increase in net assets resulting from operations dropped 53.7% to $34.0 million, largely attributable to a $25.7 million net unrealized loss on investments (compared to a $12.8 million gain in 2024) and lower investment income.
- Debt Reduction: Total debt outstanding decreased from $558.3 million in 2024 to $437.3 million in 2025, as the company repaid the December 2026 Notes and August 2027 Notes and reduced borrowings under its Credit Facility.
- Stock Performance: The common stock traded at a significant discount to NAV, closing at $7.88 on March 9, 2026, representing a 41% discount to the year-end NAV of $13.42.
Guidance, Outlook, and Risks
Merger Activity: The company is in the process of merging with SWK Holdings Corporation ("SWK") pursuant to an agreement dated October 9, 2025. The filing highlights risks related to the integration of portfolios, potential failure to realize cost savings, and the possibility of the merger not closing due to stockholder approval or other conditions.
Management Commentary: Management notes that the venture debt market is estimated at $62.4 billion. They anticipate the market for borrowers will gradually improve over coming quarters despite broader economic challenges. The company continues to pursue its strategy of Sponsored and Non-Sponsored Growth Lending.
Key Risks:
- Valuation Uncertainty: A significant portion of the portfolio consists of private securities valued at fair value by the Board, which involves subjective judgment and may differ from realized values.
- Interest Rate Sensitivity: While 95.1% of the debt portfolio bears variable interest rates, rising rates increase borrowing costs. A hypothetical 200 basis point increase in rates could increase net income by $9.6 million, while a decrease could reduce it by $4.6 million.
- Asset Quality: As of December 31, 2025, 8.23% of the debt portfolio (by fair value) was rated Category 4 or 5 (performing materially below plan or going concern in question), including Mingle Healthcare Solutions, Inc., which is on non-accrual status.
- Liquidity and Leverage: The company relies on a $550 million Credit Facility and unsecured notes. Failure to maintain asset coverage ratios could restrict distributions and borrowing capacity.
Investor Verification Checklist
- Merger Status: Verify the current status of the proposed merger with SWK Holdings Corporation and the likelihood of closing.
- Discount to NAV: Assess the sustainability of the ~41% discount at which the stock trades relative to NAV and the company's ability to raise equity capital at current prices.
- Non-Accrual Assets: Review the specific details and recovery prospects for Mingle Healthcare Solutions, Inc. and other Category 4/5 assets.
- Debt Maturity Wall: Confirm the repayment schedule for the $25 million April 2026 Notes and the refinancing strategy for the Credit Facility maturing in 2029.
- Unfunded Commitments: Verify the $145.5 million in unfunded commitments and the company's liquidity position to fund these obligations if drawn.